E. Heidemann

1.3k total citations
42 papers, 793 citations indexed

About

E. Heidemann is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, E. Heidemann has authored 42 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in E. Heidemann's work include Cancer Treatment and Pharmacology (12 papers), Breast Cancer Treatment Studies (9 papers) and Chemotherapy-related skin toxicity (4 papers). E. Heidemann is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Breast Cancer Treatment Studies (9 papers) and Chemotherapy-related skin toxicity (4 papers). E. Heidemann collaborates with scholars based in Germany, United States and Austria. E. Heidemann's co-authors include Ali Aldaoud, Sonja Martin, Ulrich Dührsen, Hjalmar B. Steinhauer, Bernhard Wörmann, Eva Hoster, Bernd Metzner, Hartmut Eimermacher, Martin Dreyling and Wolfgang Hiddemann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

E. Heidemann

42 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Heidemann Germany 12 509 433 220 155 111 42 793
J Chauvergne France 16 353 0.7× 228 0.5× 75 0.3× 208 1.3× 66 0.6× 107 833
Patrizia Gentilini Italy 10 376 0.7× 389 0.9× 113 0.5× 88 0.6× 53 0.5× 26 618
Andrea Janíková Czechia 15 378 0.7× 425 1.0× 154 0.7× 75 0.5× 43 0.4× 81 699
Garry Forgeson New Zealand 14 494 1.0× 174 0.4× 70 0.3× 229 1.5× 63 0.6× 22 918
C C Zielinski Austria 13 266 0.5× 137 0.3× 66 0.3× 201 1.3× 56 0.5× 25 570
L. E. Shepherd Canada 15 534 1.0× 185 0.4× 52 0.2× 184 1.2× 307 2.8× 43 800
C. Nouvel France 10 254 0.5× 384 0.9× 219 1.0× 109 0.7× 22 0.2× 16 600
Scot Sorensen United States 9 260 0.5× 472 1.1× 169 0.8× 150 1.0× 24 0.2× 10 602
Timothy P. Spiro United States 14 289 0.6× 122 0.3× 115 0.5× 132 0.9× 161 1.5× 32 700
Giovanna Motta Italy 15 225 0.4× 206 0.5× 86 0.4× 88 0.6× 48 0.4× 45 621

Countries citing papers authored by E. Heidemann

Since Specialization
Citations

This map shows the geographic impact of E. Heidemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Heidemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Heidemann more than expected).

Fields of papers citing papers by E. Heidemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Heidemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Heidemann. The network helps show where E. Heidemann may publish in the future.

Co-authorship network of co-authors of E. Heidemann

This figure shows the co-authorship network connecting the top 25 collaborators of E. Heidemann. A scholar is included among the top collaborators of E. Heidemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Heidemann. E. Heidemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schroth, Werner, Stefan Winter, Florian Büttner, et al.. (2015). Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype. Breast Cancer Research and Treatment. 155(1). 85–97. 22 indexed citations
2.
Fritz, Péter, Klaus Bendrat, Maike Sonnenberg, et al.. (2014). Tubular breast cancer. A retrospective study.. PubMed. 34(7). 3647–56. 11 indexed citations
3.
Meisner, Christoph, et al.. (2011). Benchmarking der Ergebnisqualität am Onkologischen Schwerpunkt Stuttgart. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 105(5). 365–370. 5 indexed citations
4.
Heidemann, E., et al.. (2004). Bleiintoxikation durch Einnahme ayurvedischer Arzneimittel. Medizinische Klinik. 99(8). 476–480. 11 indexed citations
5.
6.
Engel, Jutta, Gabriele Nagel, Eun‐Kyoung Breuer, et al.. (2002). Primary breast cancer therapy in six regions of Germany. European Journal of Cancer. 38(4). 578–585. 33 indexed citations
7.
Meyskens, FL, Marianne Gerber, F. de Waard, et al.. (2000). WHO consensus conference on diet and cancer. European Journal of Cancer Prevention. 9(3). 213–216. 4 indexed citations
8.
Heidemann, E.. (1999). [What do we know about the prevalence of pain caused by malignancy?].. PubMed. 13(4). 249–52. 3 indexed citations
9.
Heidemann, E., B. Steinke, J. Hartlapp, et al.. (1993). Prognostic Subgroups: The Key Factor for Treatment Outcome in Metastatic Breast Cancer. Oncology Research and Treatment. 16(5). 344–353. 10 indexed citations
10.
Steinke, B., H.-M. Reinold, Manfred Heim, et al.. (1992). Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP. European Journal of Cancer. 28(1). 100–104. 5 indexed citations
11.
Heidemann, E., et al.. (1991). Graduated WHO Analogue and Satisfaction Scales for the Assessment of Quality of Life in Clinical Trials in Cancer Patients. Oncology Research and Treatment. 14(5). 419–426. 3 indexed citations
12.
Heidemann, E.. (1990). Therapeutische Aspekte des fortgeschrittenen Hochrisiko-Mammakarzinoms. Oncology Research and Treatment. 13(5). 338–344. 1 indexed citations
13.
Schabet, Martin, et al.. (1986). Diagnosis and Treatment of Meningeal Carcinomatosis in Ten Patients with Breast Cancer. European Neurology. 25(6). 403–411. 15 indexed citations
14.
Heidemann, E., et al.. (1986). Recombinant interferon alpha 2 stimulation of target-binding by natural killer cells. Journal of Molecular Medicine. 64(20). 1036–1040. 5 indexed citations
15.
Heidemann, E., et al.. (1984). Günstigerer Verlauf des Herpes zoster bei immunsupprimierten Patienten unter Behandlung mit Fibroblasteninterferon. Oncology Research and Treatment. 7(4). 210–212. 4 indexed citations
16.
Heidemann, E., et al.. (1982). Effect of human fibroblast interferon on natural killer cell activity: Stimulation in vitro and inhibition in vivo. Journal of Molecular Medicine. 60(12). 625–629. 5 indexed citations
17.
Heidemann, E., et al.. (1981). Alkoholtoxische Veränderungen der Hämatopoiese: Eine prospektive Studie bei chronischen Alkoholikern. Journal of Molecular Medicine. 59(23). 1303–1312. 1 indexed citations
18.
Heidemann, E., et al.. (1979). Tissue-specific inhibitor of lymphocyte proliferation extracted and purified from calf spleen. Annals of Hematology. 39(4). 271–279. 8 indexed citations
19.
Heidemann, E., et al.. (1979). Weitere Anreicherung eines gewebsspezifischen Inhibitors der Lymphopoese (Lymphozytenchalon?). Annals of Hematology. 39(2). 99–106. 3 indexed citations
20.
Heidemann, E., et al.. (1977). Proliferationshemmung der AKR-M�useleuk�mie in vivo mit Kalbsmilzextrakt (Lymphozytenchalon). Annals of Hematology. 34(5). 381–383. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Chauvergne Breakdown of academic impact, for papers by Patrizia Gentilini Breakdown of academic impact, for papers by Andrea Janíková Breakdown of academic impact, for papers by Garry Forgeson Breakdown of academic impact, for papers by C C Zielinski Breakdown of academic impact, for papers by L. E. Shepherd Breakdown of academic impact, for papers by C. Nouvel Breakdown of academic impact, for papers by Scot Sorensen Breakdown of academic impact, for papers by Timothy P. Spiro Breakdown of academic impact, for papers by Giovanna Motta
Rankless by CCL
2026